Product Information
XCOPRI 50-100 MG TITRATION PAK is a brand product labeled by SK Life Science, Inc., priced at $42.7223 per EA under NDC 71699020228. Its NADAC has been published 245 times since Oct 20, 2021.
Manufacturer
SK Life Science, Inc.NDC
71699020228
Classification
Brand
Dosage Form
KIT
Route
ORAL
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA212839On Market Since
3/12/2020
Price Statistics
The NADAC for XCOPRI 50-100 MG TITRATION PAK has been published 245 times since Oct 20, 2021, and over the history we have for it it has risen 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.7223 per EA |
|---|---|
| All-time high | $42.7280 (Jun 10, 2026) |
| All-time low | $35.3524 (Oct 20, 2021) |
| 52-week high | $42.7280 |
| 52-week low | $41.4324 |
| Median price | $40.4579 |
| Average price | $39.3605 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 245 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of XCOPRI 50-100 MG TITRATION PAK?
The current National Average Drug Acquisition Cost (NADAC) for XCOPRI 50-100 MG TITRATION PAK, manufactured by SK Life Science, Inc., is $42.7223 per EA (NDC 71699020228), effective Jun 24, 2026.
How has the price of XCOPRI 50-100 MG TITRATION PAK changed over time?
Over the history we have for it, the NADAC for XCOPRI 50-100 MG TITRATION PAK has risen 20.8%. It has been tracked across 245 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for XCOPRI 50-100 MG TITRATION PAK?
Since Oct 20, 2021, the NADAC for XCOPRI 50-100 MG TITRATION PAK has ranged from a low of $35.3524 (Oct 20, 2021) to a high of $42.7280 (Jun 10, 2026), with a median of $40.4579 per EA.
Are there cheaper alternatives to XCOPRI 50-100 MG TITRATION PAK?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, XCOPRI 12.5-25 MG TITRATION PK, is $3.9069 per EA — about 91% below XCOPRI 50-100 MG TITRATION PAK.
Who manufactures XCOPRI 50-100 MG TITRATION PAK?
XCOPRI 50-100 MG TITRATION PAK (NDC 71699020228) is labeled by SK Life Science, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification